These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

909 related articles for article (PubMed ID: 22298358)

  • 1. Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function.
    Jung SY; Choi JH; Kwon SM; Masuda H; Asahara T; Lee YM
    J Cell Biochem; 2012 May; 113(5):1478-87. PubMed ID: 22298358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
    Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
    Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of glyceollins on vasculogenesis through suppression of endothelial progenitor cell function.
    Choi JH; Nguyen MP; Jung SY; Kwon SM; Jee JG; Bae JS; Lee S; Lee MY; Lee YM
    Mol Nutr Food Res; 2013 Oct; 57(10):1762-71. PubMed ID: 23784812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deguelin inhibits vasculogenic function of endothelial progenitor cells in tumor progression and metastasis via suppression of focal adhesion.
    Nguyen MP; Lee D; Lee SH; Lee HE; Lee HY; Lee YM
    Oncotarget; 2015 Jun; 6(18):16588-600. PubMed ID: 26078334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of angiogenic attributes by decursin in endothelial cells and ex vivo rat aortic ring angiogenesis model.
    Bhat TA; Moon JS; Lee S; Yim D; Singh RP
    Indian J Exp Biol; 2011 Nov; 49(11):848-56. PubMed ID: 22126016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fracture induced mobilization and incorporation of bone marrow-derived endothelial progenitor cells for bone healing.
    Matsumoto T; Mifune Y; Kawamoto A; Kuroda R; Shoji T; Iwasaki H; Suzuki T; Oyamada A; Horii M; Yokoyama A; Nishimura H; Lee SY; Miwa M; Doita M; Kurosaka M; Asahara T
    J Cell Physiol; 2008 Apr; 215(1):234-42. PubMed ID: 18205179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decursin inhibited proliferation and angiogenesis of endothelial cells to suppress diabetic retinopathy via VEGFR2.
    Yang Y; Yang K; Li Y; Li X; Sun Q; Meng H; Zeng Y; Hu Y; Zhang Y
    Mol Cell Endocrinol; 2013 Sep; 378(1-2):46-52. PubMed ID: 23684887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptide enhances vasculogenesis by promoting number and functional properties of early endothelial progenitor cells.
    Shmilovich H; Ben-Shoshan J; Tal R; Afek A; Barshack I; Maysel-Auslander S; Harats D; Keren G; George J
    Tissue Eng Part A; 2009 Sep; 15(9):2741-9. PubMed ID: 19275472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells.
    Plummer PN; Freeman R; Taft RJ; Vider J; Sax M; Umer BA; Gao D; Johns C; Mattick JS; Wilton SD; Ferro V; McMillan NA; Swarbrick A; Mittal V; Mellick AS
    Cancer Res; 2013 Jan; 73(1):341-52. PubMed ID: 22836757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.
    Verma S; Kuliszewski MA; Li SH; Szmitko PE; Zucco L; Wang CH; Badiwala MV; Mickle DA; Weisel RD; Fedak PW; Stewart DJ; Kutryk MJ
    Circulation; 2004 May; 109(17):2058-67. PubMed ID: 15078802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis.
    Gao D; Nolan DJ; Mellick AS; Bambino K; McDonnell K; Mittal V
    Science; 2008 Jan; 319(5860):195-8. PubMed ID: 18187653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice.
    Davidoff AM; Ng CY; Brown P; Leary MA; Spurbeck WW; Zhou J; Horwitz E; Vanin EF; Nienhuis AW
    Clin Cancer Res; 2001 Sep; 7(9):2870-9. PubMed ID: 11555605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction.
    Hamada H; Kim MK; Iwakura A; Ii M; Thorne T; Qin G; Asai J; Tsutsumi Y; Sekiguchi H; Silver M; Wecker A; Bord E; Zhu Y; Kishore R; Losordo DW
    Circulation; 2006 Nov; 114(21):2261-70. PubMed ID: 17088460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels.
    Bauer SM; Bauer RJ; Liu ZJ; Chen H; Goldstein L; Velazquez OC
    J Vasc Surg; 2005 Apr; 41(4):699-707. PubMed ID: 15874936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rg3 inhibits endothelial progenitor cell differentiation through attenuation of VEGF-dependent Akt/eNOS signaling.
    Kim JW; Jung SY; Kwon YH; Lee SH; Lee JH; Lee BY; Kwon SM
    Phytother Res; 2012 Sep; 26(9):1286-93. PubMed ID: 22253055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial NO synthase expression.
    Loomans CJ; Wan H; de Crom R; van Haperen R; de Boer HC; Leenen PJ; Drexhage HA; Rabelink TJ; van Zonneveld AJ; Staal FJ
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1760-7. PubMed ID: 16728651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis.
    Masuda H; Kalka C; Takahashi T; Yoshida M; Wada M; Kobori M; Itoh R; Iwaguro H; Eguchi M; Iwami Y; Tanaka R; Nakagawa Y; Sugimoto A; Ninomiya S; Hayashi S; Kato S; Asahara T
    Circ Res; 2007 Sep; 101(6):598-606. PubMed ID: 17656679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury.
    Iwakura A; Luedemann C; Shastry S; Hanley A; Kearney M; Aikawa R; Isner JM; Asahara T; Losordo DW
    Circulation; 2003 Dec; 108(25):3115-21. PubMed ID: 14676142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using the transcription factor inhibitor of DNA binding 1 to selectively target endothelial progenitor cells offers novel strategies to inhibit tumor angiogenesis and growth.
    Mellick AS; Plummer PN; Nolan DJ; Gao D; Bambino K; Hahn M; Catena R; Turner V; McDonnell K; Benezra R; Brink R; Swarbrick A; Mittal V
    Cancer Res; 2010 Sep; 70(18):7273-82. PubMed ID: 20807818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.